Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fascia Iliaca Block for Thromboembolectomy
NCT03798834Completed
- Sponsor
- Mansoura University
- Start
- Nov 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in Chronic Limb-Threatening Ischemia (CLTI) (2 arms), sponsored by Mansoura University. Primary endpoint: Proportion of patients who did not require conversion to general anesthesia at 30 minutes. Started Nov 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
Chronic Limb-Threatening Ischemia (CLTI)
Beyond the preview
Go deeper on NCT03798834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03798834.